Dr. Yehoshua Gleicher, MD, MSc
Claim this profileMount Sinai Hospital
Studies Total Knee Replacement
Studies Conduction Anesthesia
6 reported clinical trials
10 drugs studied
Affiliated Hospitals
Clinical Trials Yehoshua Gleicher, MD, MSc is currently running
Low vs High Concentration Local Anesthesia
for Hip Replacement
Fascia iliaca compartment block (FICB) is a documented option for postoperative analgesia for total hip arthroplasty (THA) surgery. FICB is demonstrated to be effective in terms of analgesia and opioid requirements decrease, however it causes quadriceps motor weakness. Current available motor sparing techniques are not as effective as FICB for analgesia. Low concentration local anesthetics (LCLA) are used with excellent results for pain control with no or minimum motor block effect, in other scenarios (highlighted in obstetric anesthesia) and techniques (epidural anesthesia, for instance). This study proposes that LCLA-FICB can offer the benefit of peripheral nerve blocks mediated analgesia, while at the same time avoiding motor blockade and muscle weakness. The investigators hypothesize that LCLA-FICB, when compared to conventional high concentration local anesthetics (HCLA) FICB, provides similar postoperative analgesia in the first 24 hours following primary THA, while at the same time preserving quadriceps muscle group strength.
Recruiting1 award N/A3 criteria
Nerve Block
for Total Knee Replacement
Total knee arthroplasty (TKA) is a frequent performed surgery. Many institutions are implementing fast track programs for this surgery and adequate pain management is an important feature. Analgesic duration of single shot nerve blocks is limited to no more than 24h. Conversely, the use of continuous nerve block (CNB) through a perineural catheter and infusion of local anesthetic may increase duration of analgesia and provide better outcomes. The purpose of this study is to evaluate effectiveness and safety of using CNB in patients undergoing ambulatory TKA, and its effects on patients' quality of recovery. Investigators hypothesize that continuous adductor canal block would lead to decrease in opioid consumption in patients undergoing fast track TKA. Significance There are no published prospective randomized controlled trials to assess patient's reported quality of recovery after receiving CACB in same day primary knee arthroplasties. As this is a frequent type of surgery and has the prediction to increase its incidence for the next years, there is significant importance in investigations about interventions which may improve its recovery in a fast track regime. A postoperative analgesic technique that offers better pain control, has less adverse effects, reduces the opioid analgesia requirement and is safe to be used in a fast track setting may have additional impact on decreasing health care cost and may lead to an enhanced recovery and better quality of life. Objectives To evaluate effectiveness and safety of using CACB in patients undergoing ambulatory TKA, in comparison to SACB. Primary objective is opioid consumption (in oral morphine equivalent doses) Secondary objectives are to evaluate postoperative QoR-15 scores (10), pain scores, opioid-induced adverse effects (measured via validated opioid symptom distress scale), postoperative functional status, complications relating to the perineural catheter and readmissions.
Recruiting0 awards N/A
More about Yehoshua Gleicher, MD, MSc
Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Yehoshua Gleicher, MD, MSc has experience with
- ISAFE
- Conventional Technique
- Self Exploring Of Available Online Material On Supraclavicular Brachial Plexus Block
- Conventional In-person Teaching On Supraclavicular Brachial Plexus Block
- Continuous Adductor Canal Block (CACB)
- Sham Continuous Adductor Canal Block (ShACB)
Breakdown of trials Yehoshua Gleicher, MD, MSc has run
Total Knee Replacement
Conduction Anesthesia
Knee Replacement Surgery
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Yehoshua Gleicher, MD, MSc specialize in?
Yehoshua Gleicher, MD, MSc focuses on Total Knee Replacement and Conduction Anesthesia. In particular, much of their work with Total Knee Replacement has involved treating patients, or patients who are undergoing treatment.
Is Yehoshua Gleicher, MD, MSc currently recruiting for clinical trials?
Yes, Yehoshua Gleicher, MD, MSc is currently recruiting for 4 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Yehoshua Gleicher, MD, MSc has studied deeply?
Yes, Yehoshua Gleicher, MD, MSc has studied treatments such as ISAFE, Conventional technique, Self exploring of available online material on supraclavicular brachial plexus block.
What is the best way to schedule an appointment with Yehoshua Gleicher, MD, MSc?
Apply for one of the trials that Yehoshua Gleicher, MD, MSc is conducting.
What is the office address of Yehoshua Gleicher, MD, MSc?
The office of Yehoshua Gleicher, MD, MSc is located at: Mount Sinai Hospital, Toronto, Ontario M5G 1X5 Canada. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.